304 related articles for article (PubMed ID: 7817382)
1. Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: matching for transplants from related haploidentical donors.
Mickelson EM; Guthrie LA; Etzioni R; Anasetti C; Martin PJ; Hansen JA
Tissue Antigens; 1994 Aug; 44(2):83-92. PubMed ID: 7817382
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation.
Mickelson EM; Longton G; Anasetti C; Petersdorf E; Martin P; Guthrie LA; Hansen JA
Tissue Antigens; 1996 Jan; 47(1):27-36. PubMed ID: 8929710
[TBL] [Abstract][Full Text] [Related]
3. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
4. Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses.
Mazzola G; el-Borai MH; Berrino M; Cornaglia M; Amoroso A
Bone Marrow Transplant; 1993; 11 Suppl 1():24-7. PubMed ID: 8095414
[TBL] [Abstract][Full Text] [Related]
5. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
[TBL] [Abstract][Full Text] [Related]
6. A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients.
Martin PJ; Rowley SD; Anasetti C; Chauncey TR; Gooley T; Petersdorf EW; van Burik JA; Flowers ME; Storb R; Appelbaum FR; Hansen JA
Blood; 1999 Oct; 94(7):2192-9. PubMed ID: 10498588
[TBL] [Abstract][Full Text] [Related]
7. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation.
Petersdorf EW; Longton GM; Anasetti C; Martin PJ; Mickelson EM; Smith AG; Hansen JA
Blood; 1995 Aug; 86(4):1606-13. PubMed ID: 7632970
[TBL] [Abstract][Full Text] [Related]
8. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.
Petersdorf EW; Kollman C; Hurley CK; Dupont B; Nademanee A; Begovich AB; Weisdorf D; McGlave P
Blood; 2001 Nov; 98(10):2922-9. PubMed ID: 11698272
[TBL] [Abstract][Full Text] [Related]
9. Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs.
Santamaria P; Reinsmoen NL; Lindstrom AL; Boyce-Jacino MT; Barbosa JJ; Faras AJ; McGlave PB; Rich SS
Blood; 1994 Jan; 83(1):280-7. PubMed ID: 8274743
[TBL] [Abstract][Full Text] [Related]
10. Lack of correlation of MLC reactivity with acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
Segall M; Noreen H; Edwins L; Haake R; Shu XO; Kersey J
Hum Immunol; 1996 Aug; 49(1):49-55. PubMed ID: 8839775
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
Przepiorka D; Saliba R; Cleary K; Fischer H; Tonai R; Fritsche H; Khouri IF; Folloder J; Ueno NT; Mehra R; Ippoliti C; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Anderlini P; Andersson BS; Champlin R
Biol Blood Marrow Transplant; 2000; 6(2A):190-7. PubMed ID: 10816027
[TBL] [Abstract][Full Text] [Related]
12. Low incidence of acute GVHD in patients transplanted with marrow from HLA-A,B,DR-compatible unrelated donors among Japanese.
Morishima Y; Kodera Y; Hirabayashi N; Tanimoto M; Matsuyama T; Horibe K; Ohta H; Mizuno S; Morishita Y; Yamauchi T
Bone Marrow Transplant; 1995 Feb; 15(2):235-9. PubMed ID: 7773212
[TBL] [Abstract][Full Text] [Related]
13. Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts.
Drobyski WR; Klein J; Flomenberg N; Pietryga D; Vesole DH; Margolis DA; Keever-Taylor CA
Blood; 2002 Feb; 99(3):806-14. PubMed ID: 11806980
[TBL] [Abstract][Full Text] [Related]
14. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
[TBL] [Abstract][Full Text] [Related]
16. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
17. The MLC assay as a test for HLA-D region compatibility between patients and unrelated donors: results of a national marrow donor program involving multiple centers.
Mickelson EM; Bartsch GE; Hansen JA; Dupont B
Tissue Antigens; 1993 Nov; 42(5):465-72. PubMed ID: 8146857
[TBL] [Abstract][Full Text] [Related]
18. HLA-DP incompatibilities induce significant proliferation in primary mixed lymphocyte cultures in HLA-A, -B, -DR and -DQ compatible individuals: implications for allogeneic bone marrow transplantation.
Olerup O; Möller E; Persson U
Tissue Antigens; 1990 Nov; 36(5):194-202. PubMed ID: 1982746
[TBL] [Abstract][Full Text] [Related]
19. CD31 mismatching affects marrow transplantation outcome.
Grumet FC; Hiraki DD; Brown BWM ; Zehnder JL; Zacks ES; Draksharapu A; Parnes J; Negrin RS
Biol Blood Marrow Transplant; 2001; 7(9):503-12. PubMed ID: 11669217
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient.
Spencer A; Szydlo RM; Brookes PA; Kaminski E; Rule S; van Rhee F; Ward KN; Hale G; Waldmann H; Hows JM; Batchelor JR; Goldman JM
Blood; 1995 Nov; 86(9):3590-7. PubMed ID: 7579468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
